TSE:IMV IMV (IMV) Stock Price, News & Analysis C$1.12 -0.02 (-1.75%) (As of 04/28/2023) Add Compare Share Share Stock Analysis Stock Analysis About IMV Stock (TSE:IMV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IMV alerts:Sign Up Key Stats Today's RangeC$1.07▼C$1.1350-Day RangeC$1.12▼C$1.1252-Week RangeC$0.62▼C$15.90Volume15,761 shsAverage Volume56,822 shsMarket CapitalizationC$13.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.Read More… Rigged election? (Ad)Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Receive IMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter. Email Address IMV Stock News HeadlinesPET MRI Market Set to Reach $494.7 Million by 2034 with 9.1% CAGR Growth | Fact.MR ReportOctober 22, 2024 | finance.yahoo.comNew single-chain mRNA vaccines offer enhanced immunity and protection against mpoxOctober 22, 2024 | msn.comRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. November 4, 2024 | Porter & Company (Ad)'Animals' Ben Affleck and Matt Damon Netflix Movie Currently on HoldSeptember 27, 2024 | msn.com‘Are you okay?’: Daily free service saves a life in CantonSeptember 26, 2024 | msn.comTwo arrested as man treated for head injury following Belfast assaultSeptember 11, 2024 | msn.comAlabama Crimson Tide HC Kalen DeBoer still playing coy regarding injury status of star playerSeptember 5, 2024 | msn.comIMV INC (IMVIF)August 22, 2024 | uk.finance.yahoo.comSee More Headlines IMV Stock Analysis - Frequently Asked Questions How have IMV shares performed this year? IMV's stock was trading at C$1.12 at the start of the year. Since then, IMV stock has increased by 0.0% and is now trading at C$1.12. View the best growth stocks for 2024 here. When did IMV's stock split? IMV's stock reverse split before market open on Monday, December 12th 2022. The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of IMV? Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of IMV own? Based on aggregate information from My MarketBeat watchlists, some other companies that IMV investors own include Aurora Cannabis (ACB), 10094 (IRD.TO) (IRD), Manulife Financial (MFC), Village Farms International (VFF), Bombardier, Inc. Class B (BBD.B), Cronos Group (MJN) and Enbridge (ENB). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryComputer Hardware Current SymbolTSE:IMV CUSIPN/A CIKN/A Webwww.imvaccine.com Phone+1-902-4921819FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($6.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-37,990,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-508.58% Return on Assets-61.78% Debt Debt-to-Equity Ratio1,231.01 Current Ratio2.93 Quick Ratio2.32 Sales & Book Value Annual SalesC$23,000.00 Price / Sales570.23 Cash FlowC$0.70 per share Price / Cash Flow1.61 Book ValueC($0.69) per share Price / Book-1.62Miscellaneous Outstanding Shares11,710,000Free FloatN/AMarket CapC$13.12 million OptionableNot Optionable Beta1.52 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (TSE:IMV) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMV Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMV With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.